DOI: 10.1055/s-00000059

Pneumologie

Referenz

Vestbo J, Anderson JA, Brook RD. et al.
Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.

Lancet 2016;
387: 1817-1826

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: